[1] |
谢金波,彭波.良性前列腺增生的流行病学特征及危险因素研究进展[J].同济大学学报(医学版),2021,42(4): 568-573.DOI:10.12289/j.issn.1008-0392.20187.Xie JB,Peng B.Epidemiological characteristics and risk factors of benign prostatic hyperplasia: an update[J].J Tongji Univ Med Sci,2021,42(4): 568-573.DOI: 10.12289/j.issn.1008-0392.20187.
|
[2] |
Devlin CM,Simms MS,Maitland NJ.Benign prostatic hyperplasiawhat do we know?[J].BJU Int,2021,127(4): 389-399.DOI: 10.1111/bju.15229.
|
[3] |
Miernik A,Gratzke C.Current treatment for benign prostatic hyperplasia[J].Deutsches Arzteblatt international,2020,117(49):843-854.DOI: 10.3238/arztebl.2020.0843.
|
[4] |
Ofoha CG,Raphael JE,Dakum NK,et al.Surgical management of benign prostate hyperplasia in Nigeria: open prostatectomy versus transurethral resection of the prostate[J].Pan Afr Med J,2021,39:165.DOI: 10.11604/pamj.2021.39.165.24767.
|
[5] |
Lotterstätter M,Seklehner S,Wimpissinger F,et al.Transurethral resection of the prostate in 85+ patients: a retrospective,multicentre study[J].World J Urol,2022,40(12): 3015-3020.DOI: 10.1007/s00345-022-04179-w.
|
[6] |
Knight L,Peirce S,Morris R.The PLASMA system for transurethral resection of the prostate: a NICE medical technologies guidance update[J].Appl Health Econ Health Policy,2021,19(5): 665-672.DOI: 10.1007/s40258-021-00651-7.
|
[7] |
杨亚汉.经尿道前列腺切开术在高危前列腺增生治疗中的应用效果分析[J].中国当代医药,2017,24(25): 66-68.DOI: 10.3969/j.issn.1674-4721.2017.25.021.Yang YH.Application effect analysis of transurethral prostatectomy in the treatment of high risk benign prostatic hyperplasia[J].China Mod Med,2017,24(25): 66-68.DOI: 10.3969/j.issn.1674-4721.2017.25.021.
|
[8] |
邵长富,于乐广,吴育栋,等.不同手术方式治疗小体积前列腺增生的网状meta 分析 [J].临床泌尿外科杂志,2023,38 (10): 748-754.DOI: 10.13201/j.issn.1001-1420.2023.10.005.Shao CF,Yu LG,Wu YD,et al.Net meta-analysis of different surgical modalities for the treatment of small-volume prostatic hyperplasia [J].J Clin Urol,2023,38 (10): 748-754.DOI: 10.13201/j.issn.1001-1420.2023.10.005.
|
[9] |
Marra G,Sturch P,Oderda M,et al.Systematic review of lower urinary tract symptoms/benign prostatic hyperplasia surgical treatments on men's ejaculatory function: Time for a bespoke approach?[J].Int J Urol,2016,23(1): 22-35.DOI: 10.1111/iju.12866.
|
[10] |
王立民,胡锦洋,李立坤,等.经尿道柱状水囊前列腺扩开术治疗良性前列腺增生的临床疗效分析[J].中华男科学杂志,2021,27(2): 150-154.DOI: 10.13236/j.cnki.nja.2021.02.009.Wang LM,Hu JY,Li LK,et al.Transurethral columnar balloon dilation of the prostate for benign prostatic hyperplasia[J].Natl J Androl,2021,27(2): 150-154.DOI: 10.13236/j.cnki.nja.2021.02.009.
|
[11] |
Zhou G,He J,Huang G,et al.Efficacy and safety of transurethral columnar balloon dilation of the prostate for the treatment of benign prostatic hyperplasia: a multicenter trial[J].Comput Math Methods Med,2022,2022: 7881247.DOI: 10.1155/2022/7881247.
|
[12] |
Patard PM,Roumiguie M,Sanson S,et al.Endoscopic enucleation for prostate larger than 60 mL: comparison between holmium laser enucleation and plasmakinetic enucleation[J].World J Urol,2021,39(6): 2011-2018.DOI: 10.1007/s00345-020-03382-x.
|
[13] |
Su W,Yi Y,Zeng L,et al.Research on applications of transurethral plasmakinetic enucleation of the prostate in elderly patients aged ≥80 years[J].Front Surg,2021,8: 775548.DOI: 10.3389/fsurg.2021.775548.
|
[14] |
Giulianelli R,Gentile BC,Mirabile G,et al.Bipolar plasma enucleation of the prostate vs.open prostatectomy in large benign prostatic hyperplasia: a single centre 3-year comparison[J].Prostate Cancer Prostatic Dis,2019,22(1): 110-116.DOI: 10.1038/s41391-018-0080-7.
|
[15] |
黄健,张旭.中国泌尿外科和男科疾病诊断治疗指南:2022 版[M].北京: 人民卫生出版社,2022.Huang J,Zhang Xu.Diagnosis and treatment Guidelines for Urological and Andrological diseases in China:2022 Edition[M].Beijing: Science Press,2022.
|
[16] |
Heiman J,Agarwal D,Komanapalli S,et al.Outcomes of octogenarians undergoing holmium laser enucleation of prostate[J].World J Urol,2022,40(7): 1751-1754.DOI: 10.1007/s00345-022-04053-9.
|
[17] |
Tamalunas A,Westhofen T,Schott M,et al.Holmium laser enucleation of the prostate: a truly size-independent method?[J].Lower Urinary Tract Symptoms,2022,14(5): 14(1):17-26.DOI:10.1111/luts.12404.
|
[18] |
吴进锋,魏永宝,林乐,等.经尿道钬激光前列腺剜除术的技术要点和尿道黏膜保留的策略(附光盘)[J].现代泌尿外科杂志,2020,25(4): 289-292.DOI: 10.3969/j.issn.1009-8291.2020.04.001.Wu JF,Wei YB,Lin L,et al.Key techniques of transurethal holmium laser enucleation of the prostate and strate-gy for urethral mucosal retention[J].J Mod Urol,2020,25(4): 289-292.DOI: 10.3969/j.issn.1009-8291.2020.04.001.
|
[19] |
伍宏亮,汪盛,陈志军,等.经尿道选择性绿激光前列腺汽化术与经尿道等离子前列腺电切术治疗不同体积前列腺增生的结局指标比较[J].徐州医科大学学报,2024,44(4): 266-270.DOI:10.3969/j.issn.2096-3882.2024.04.006.Wu HL,Wang S,Chen ZJ,et al.Transurethral greenlight photoselective vaporization of the prostate versus transurethral plasma kinetic resection of the prostate for the treatment of prostatic hyperplasia patients with different volumes[J].J Xuzhou Med Univ,2024,44(4): 266-270.DOI: 10.3969/j.issn.2096-3882.2024.04.006.
|
[20] |
文爽,杨林,罗军,等.经尿道前列腺绿激光剜除术与前列腺电切术治疗前列腺增生症效果对比分析[J].第三军医大学学报,2020,42(18): 1868-1874.DOI: 10.16016/j.1000-5404.202004032.Wen S,Yang L,Luo J,et al.Comparison of therapeutic effects of green laser enucleation of the prostate and transurethral prostate resection for treatment of benign prostatic hyperplasia[J].J Third Mil Med Univ,2020,42(18): 1868-1874.DOI: 10.16016/j.1000-5404.202004032.
|
[21] |
Castellani D,Pirola GM,Gasparri L,et al.Are outcomes of thulium laser enucleation of the prostate different in men aged 75 and over?A propensity score analysis[J].Urology,2019,132: 170-176.DOI:10.1016/j.urology.2019.06.025.
|
[22] |
Meng C,Peng L,Li J,et al.Comparison of enucleation between thulium laser and holmium laser for benign prostatic hyperplasia:A systematic review and meta-analysis.[J].Asian J Surg,20,45(2):689-697.DOI: 10.1016/j.asjsur.2021.07.045.
|
[23] |
邱建新,张志明,聂志勇,等.经尿道蓝激光前列腺剜除手术治疗前列腺增生1 例 [J].空军军医大学学报,2022,43 (4): 381-384.DOI: 10.13276/j.issn.2097-1656.2022.03.023.Qiu JX,Zhang ZM,Nie ZY,et al.Transurethral blue laser prostate enucleation for prostatic hyperplasia in a case [J].J Air Force Med Univ,2022,43 (4): 381-384.DOI: 10.13276/j.issn.2097-1656.2022.03.023
|
[24] |
Lai S,Peng P,Diao T,et al.Comparison of photoselective green light laser vaporisation versus traditional transurethral resection for benign prostate hyperplasia: an updated systematic review and meta-analysis of randomised controlled trials and prospective studies[J].BMJ Open,2019,9(8): e028855.DOI: 10.1136/bmjopen-2018-028855.
|
[25] |
Destefanis P,Sibona M,Soria F,et al.Ejaculation-sparing versus non-ejaculation-sparing anatomic greenlight laser enucleovaporization of the prostate: first comparative study[J].World J Urol,2021,39(9): 3455-3463.DOI: 10.1007/s00345-021-03615-7.
|
[26] |
Worthington J,Lane JA,Taylor H,et al.Thulium laser transurethral vaporesection versus transurethral resection of the prostate for benign prostatic obstruction: the UNBLOCS RCT[J].Health Technol Assess,2020,24(41): 1-96.DOI: 10.3310/hta24410.
|
[27] |
杜泉,徐晓峰.蓝激光在良性前列腺增生手术中的应用[J].中国临床医生杂志,2023,51(9): 1021-1022.DOI: 10.3969/j.issn.2095-8552.2023.09.005.Du Q,Xu XF.Application of blue laser in surgery for benign prostatic hyperplasia[J].Chin J Clin,2023,51(9): 1021-1022.DOI:10.3969/j.issn.2095-8552.2023.09.005.
|
[28] |
医讯:世界首创200 W 蓝激光手术设备成功应用于临床[J].现代泌尿外科杂志,2022,27(9): 783.DOI: 10.3969/j.issn.1009-8291.2022.09.016.Medical news: The world's first 200 W blue laser surgical equipment is successfully applied in clinic[J].J Mod Urol,2022,27(9): 783.DOI: 10.3969/j.issn.1009-8291.2022.09.016.
|
[29] |
凡振伟,程海峰,杜泉,等.450 nm 蓝激光半导体治疗机汽化切除治疗良性前列腺增生100 例报告[J].现代泌尿外科杂志,2023,28(1): 24-28.DOI: 10.3969/j.issn.1009-8291.2023.01.006.Fan ZW,Cheng HF,Du Q,et al.Report of 100 cases of benign prostatic hyperplasia treated by vapor resection with 450 nm blue laser semiconductor therapy machine[J].J Mo Urol,2023,28(1): 24-28.DOI: 10.3969/j.issn.1009-8291.2023.01.006.
|
[30] |
Xu X,Jiang D,Liu G,et al.In vitro evaluation of the safety and efficacy of a high-power 450-nm semiconductor blue laser in the treatment of benign prostate hyperplasia[J].2022,37(1): 555-561.DOI: 10.1007/s10103-021-03297-y.
|
[31] |
满超,郝晓航,李腾,等.保留性功能的450 nm 蓝激光汽化术治疗前列腺增生症20 例报告[J].现代泌尿外科杂志,2023,28 (08):702-706.DOI: 10.3969/j.issn.1009-8291.2023.08.013.Man C,Hao XH,Li T,et al.Report of 20 cases of prostatic hyperplasia treated by 450 nm blue laser vaporization with preservation of sexual function[J].Journal of Modern Urology,2023,28 (08): 702-706.DOI: 10.3969/j.issn.1009-8291.2023.08.013.
|
[32] |
Ziętek RJ,Ziętek ZM.Transurethral microwave thermotherapy(TUMT) in the treatment of benign prostatic hyperplasia: a preliminary report[J].Med Sci Monit,2021,27: e931597.DOI:10.12659/MSM.931597.
|
[33] |
Law YXT,Chen WJK,Shen L,et al.Is transurethral needle ablation of prostate out of fashion? Outcomes of single session office-based transurethral needle ablation of prostate in patients with symptomatic benign prostatic hyperplasia[J].Investig Clin Urol,2019,60(5): 351-358.DOI: 10.4111/icu.2019.60.5.351.
|
[34] |
Miller LE,Chughtai B,McVary K,et al.Water vapor thermal therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: Systematic review and meta-analysis[J].Medicine,2020,99(30): e21365.DOI: 10.1097/MD.0000000000021365.
|
[35] |
McVary KT,Rogers T,Roehrborn CG.Rezūm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study[J].Urology,2019,126: 171-179.DOI: 10.1016/j.urology.2018.12.041.
|
[36] |
Westwood J,Geraghty R,Jones P,et al.Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia[J].Ther Adv Urol,2018,10(11): 327-333.DOI: 10.1177/1756287218793084.
|
[37] |
宋剑楠,张翔翔,张世革.金属支架在前列腺增生支架植入术中的临床应用现状[J].实用老年医学,2020,34(3): 301-303.DOI:10.3969/j.issn.1003-9198.2020.03.024.Song JN,Zhang XX,Zhang S.Clinical application of metal stents in prostatic hyperplasia stenting [J].Pract Geriatr,2020,34(3): 301-303.DOI: 10.3969/j.issn.1003-9198.2020.03.024.
|
[38] |
何昊玮,易晓明,许松,等.螺旋形热膨胀前列腺支架置入术26 例临床分析[J].中华男科学杂志,2019,25(5): 414-419.DOI:10.13263/j.cnki.nja.2019.05.006.He HW,Yi XM,Xu S,et al.Spiral thermo-expandable prostatic stent implantation for benign prostatic hyperplasia: Clinical analysis of 26 cases[J].Natl J Androl,2019,25(5): 414-419.DOI: 10.13263/j.cnki.nja.2019.05.006.
|
[39] |
Magistro G,Stief CG,Gratzke C.Prostatic urethral lift versus transurethral resection of the prostate (TURP)[J].Curr Urol Rep,2017,18(10): 82.DOI: 10.1007/s11934-017-0725-4.
|
[40] |
Denisenko A,Somani B,Agrawal V.Recent advances in UroLift: A comprehensive overview[J].Turk J Urol,2022,48(1): 11-16.DOI:10.5152/tud.2022.21149.
|
[41] |
Knight L,Dale M,Cleves A,et al.UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia: a nice medical technology guidance update[J].Appl Health Econ Health Policy,2022,20(5): 669-680.DOI: 10.1007/s40258-022-00735-y.
|
[42] |
Abt D,Müllhaupt G,Hechelhammer L,et al.Prostatic artery embolisation versus transurethral resection of the prostate for benign prostatic hyperplasia: 2-yr outcomes of a randomised,open-label,single-centre trial[J].Eur Urol,2021,80(1): 34-42.DOI: 10.1016/j.eururo.2021.02.008.
|
[43] |
Abt D,Schmid HP,Speakman MJ.Reasons to consider prostatic artery embolization[J].World J Urol,2021,39(7): 2301-2306.DOI:10.1007/s00345-021-03601-z.
|
[44] |
项效益.前列腺动脉栓塞术联合经尿道前列腺电切术治疗体积>80 ml 良性前列腺增生的短中期随访研究[J].临床医学,2022,42(9): 22-25.DOI: 10.19528/j.issn.1003-3548.2022.09.007.Xiang XY.A short-term and medium-term follow-up study of prostatic arterial embolization combined with transurethral resection of prostate in the treatment of benign prostatic hyperplasia with a prostate volume of 80 ml[J].Clin Med,2022,42(9): 22-25.DOI:10.19528/j.issn.1003-3548.2022.09.007.
|
[45] |
Zumstein V,Betschart P,Vetterlein MW,et al.Prostatic artery embolization versus standard surgical treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis[J].Eur Urol Focus,2019,5(6):1091-1100.DOI: 10.1016/j.euf.2018.09.005.
|
[46] |
Shah AA,Gahan JC,Sorokin I.Comparison of robot-assisted versus open simple prostatectomy for benign prostatic hyperplasia[J].Curr Urol Rep,2018,19(9): 71.DOI: 10.1007/s11934-018-0820-1.
|
[47] |
Autorino R,Zargar H,Mariano MB,et al.Perioperative outcomes of robotic and laparoscopic simple prostatectomy: a European-American multi-institutional analysis[J].Eur Urol,2015,68(1): 86-94.DOI: 10.1016/j.eururo.2014.11.044.
|
[48] |
Kim HS,Shin YS.Robotic Assisted Simple Prostatectomy versus Holmium Laser Enucleation of the Prostate for Patients with Huge Benign Prostatic Hyperplasia[J].World J Mens Health,20,41(4):753-758.
|
[49] |
滕竞飞,贾卓敏,关亚伟,等.机器人辅助腹腔镜前列腺单纯切除术治疗大体积(>80 ml)良性前列腺增生的安全性与疗效分析[J].微创泌尿外科杂志,2018,7(6): 361-365.DOI: 10.19558/j.cnki.10-1020/r.2018.06.001.Teng JF,Jia ZM,Guan YW,et al.Safety and efficacy of robot assisted simple prostatectomy in the treatment of large volume(>80 ml)benign prostate hyperplasia[J].J Minim Invasive Urol,2018,7(6): 361-365.DOI: 10.19558/j.cnki.10-1020/r.2018.06.001.
|
[50] |
Wang P,Xia D,Ye S,et al.Robotic-assisted urethra-sparing simple prostatectomy via an extraperitoneal approach[J].Urology,2018,119: 85-90.DOI: 10.1016/j.urology.2018.06.005.
|
[51] |
Gilling P,Barber N,Bidair M,et al.Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trial[J].Can J Urol,2020,27(1): 10072-10079.
|
[52] |
Bidair M,Kramolowsky E,et al.Aquablation therapy in large prostates (80-150 mL) for lower urinary tract symptoms due to benign prostatic hyperplasia: final WATER II 5-year clinical trial results[J].J Urol,2023,210(1): 143-15.DOI: 10.1097/JU.0000000000003483.
|
[53] |
Gilling P,Barber N,Bidair M,et al.Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind,randomized trial in men with LUTS due to BPH[J].Can J Urol,2022,29(1): 10960-10968.
|